Pages that link to "Q37078997"
Jump to navigation
Jump to search
The following pages link to GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism (Q37078997):
Displaying 50 items.
- The promise of neuroprotective agents in Parkinson's disease (Q21129436) (← links)
- The gut hormones in appetite regulation (Q21296779) (← links)
- Regulation of glucose homeostasis by GLP-1 (Q24563430) (← links)
- Hippocampal Neurophysiologic Changes after Mild Traumatic Brain Injury and Potential Neuromodulation Treatment Approaches (Q26768199) (← links)
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action (Q26768527) (← links)
- Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus (Q26774021) (← links)
- Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis (Q26774368) (← links)
- Parkinson's disease, insulin resistance and novel agents of neuroprotection (Q26853311) (← links)
- Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke (Q26861493) (← links)
- Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence (Q26864588) (← links)
- Linked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments (Q26995786) (← links)
- Use of glucagon-like peptide-1 agonists to improve islet graft performance (Q27013927) (← links)
- BDNF mediates adaptive brain and body responses to energetic challenges (Q27693260) (← links)
- Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes (Q28067465) (← links)
- Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide (Q28081671) (← links)
- Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis (Q28481242) (← links)
- Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model (Q28546885) (← links)
- Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats (Q28550675) (← links)
- Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons (Q28553200) (← links)
- Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria (Q28597322) (← links)
- GLP-1 improves neuropathology after murine cold lesion brain trauma (Q28651569) (← links)
- Energy intake and exercise as determinants of brain health and vulnerability to injury and disease (Q28710367) (← links)
- A synopsis on the role of tyrosine hydroxylase in Parkinson's disease (Q28830946) (← links)
- Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice (Q30531048) (← links)
- Exenatide and the treatment of patients with Parkinson's disease (Q30540208) (← links)
- Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease (Q33628048) (← links)
- Adverse stress, hippocampal networks, and Alzheimer's disease (Q33708011) (← links)
- Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines (Q33708923) (← links)
- The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care? (Q33751723) (← links)
- Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective study (Q33754087) (← links)
- The impact of dietary energy intake on cognitive aging (Q33868403) (← links)
- Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization (Q34015457) (← links)
- Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells (Q34028497) (← links)
- GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. (Q34167980) (← links)
- Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons (Q34215215) (← links)
- Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS. (Q34321059) (← links)
- Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury (Q34362412) (← links)
- Diminished mTOR signaling: a common mode of action for endocrine longevity factors. (Q34462362) (← links)
- Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. (Q34476077) (← links)
- Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease (Q34547754) (← links)
- Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model (Q34639384) (← links)
- Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward (Q34685472) (← links)
- Bidirectional metabolic regulation of neurocognitive function (Q34884241) (← links)
- Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats (Q35061438) (← links)
- Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease (Q35129144) (← links)
- Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice (Q35180081) (← links)
- GLP-1 based therapeutics: simultaneously combating T2DM and obesity. (Q35200252) (← links)
- Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetes (Q35213829) (← links)
- Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis (Q35223375) (← links)
- GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice (Q35226164) (← links)